Henry M Franzen

Title: Henry M Franzen: Innovator in Allergy Treatment

Introduction

Henry M Franzen is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of allergy treatment, particularly through his innovative work on T cell epitopes of major allergens from house dust mites. With a total of 4 patents, Franzen's inventions aim to improve therapeutic options for individuals suffering from allergies.

Latest Patents

Franzen's latest patents focus on isolated peptides of the major protein allergens from the genus Dermatophagoides. These peptides include at least one T cell epitope, or preferably at least two T cell epitopes of protein allergens such as Der p I, Der p II, Der f I, or Der f II. His inventions also encompass modified peptides that possess similar or enhanced therapeutic properties compared to naturally-occurring allergens, while minimizing side effects. Additionally, he provides nucleic acid sequences coding for these peptides, along with methods for diagnosing and treating sensitivity to house dust mites.

Career Highlights

Throughout his career, Franzen has worked with various organizations, including Immulogic Pharmaceutical Corporation. His work has been instrumental in advancing the understanding and treatment of allergies, particularly those related to house dust mites.

Collaborations

Franzen has collaborated with notable individuals in his field, including Richard D Garman and Julia L Greenstein. These partnerships have contributed to the development of his innovative solutions in allergy treatment.

Conclusion

Henry M Franzen's contributions to allergy treatment through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to impact the lives of individuals affected by allergies, paving the way for improved therapeutic options.